15 results match your criteria: "Laboratory Center for Disease Control[Affiliation]"
Ann Epidemiol
January 2001
Bureau of Reproductive and Child Health, Laboratory Center for Disease Control, Health Canada, Ottawa, Ontario.
Purpose: There has been little attention paid to asthma complicating pregnancy. This study is among the few studies that investigated this issue in a large Canadian population (more than two millions of Canadian pregnant women).
Methods: We carried out a historical cohort study using hospital discharge data collected by the Canadian Institute for Health Information for fiscal years 1989/90 to 1995/96.
Paediatr Perinat Epidemiol
October 2000
Bureau of Reproductive and Child Health, Laboratory Center for Disease Control, Health Canada, Ottawa, Ontario, Canada.
This study examined the relationship between male sex at birth and placenta praevia in 433031 mother/infant dyads (linked by a common institutional code and hospital admission number) in the Canadian province of Quebec, during the fiscal years of 1991/92-1995/96. The male-to-female ratio among pregnancies with and without placenta praevia was calculated and compared. The male-to-female ratio at birth was higher in pregnancies complicated by a placenta praevia (1.
View Article and Find Full Text PDFHelicobacter
September 2000
National Laboratory for Enteric Pathogens, Special Bacteriology Laboratory, Bureau of Microbiology, Laboratory Center for Disease Control, and Cangene Corporation, Winnipeg, Manitoba, Canada.
Background: Helicobacter pullorum, first detected in the liver and intestinal contents of poultry, was defined as a new species in 1994. This organism has since been isolated from humans with gastroenteritis. Phenotypic as well as genotypic methods have been used to identify H.
View Article and Find Full Text PDFJ Clin Microbiol
November 1998
Influenza and Respiratory Viruses, Bureau of Microbiology, Laboratory Center for Disease Control, Federal Laboratories, Winnipeg, Manitoba R3M 3R2, Canada.
Diagnosis of respiratory virus infections currently involves detection by isolation or antigen detection, which usually identifies only a single suspected agent. To permit identification of more than one respiratory virus in clinical specimens, a rapid detection method involving a single-step, multiplex reverse transcription-PCR (RT-PCR) assay was developed. The assay included five primer sets that amplified the RNA of respiratory syncytial virus subtypes A and B, parainfluenza virus types 1, 2, and 3, and adenovirus types 1 to 7.
View Article and Find Full Text PDFClin Lab Med
September 1996
National Reference Center for Tuberculosis, Laboratory Center for Disease Control, Health Canada, Ottawa, Ontario, Canada.
Tuberculosis causes more deaths worldwide than any other single infectious disease. Most new cases occur in developing countries, where the emergence of HIV/AIDS-associated multidrug-resistant Mycobacterium tuberculosis could disrupt the effective delivery of chemotherapy. Diagnosis, one of the cornerstones of the modern national tuberculosis control programs in developing countries, is based on sputum smear microscopy, which can be delivered effectively only through a national laboratory network.
View Article and Find Full Text PDFEpidemiol Rev
April 1997
Bureau of Reproductive and Child Health, Laboratory Center for Disease Control, Ottawa, Ontario, Canada.
Can J Oncol
November 1994
Cancer Division, Laboratory Center for Disease Control, Ottawa, Ontario.
Bull World Health Organ
November 1994
WHO Collaborating Center for Tuberculosis Bacteriological Research, Laboratory Center for Disease Control, Ottawa, Ontario, Canada.
A random sample survey of initial drug resistance among cases of tuberculosis in Latin America was carried out during the second half of the 1980s and the early 1990s. A total of 948 cultures of Mycobacterium tuberculosis isolated from patients presumed never before to have been treated for tuberculosis were collected from 30 randomly selected clusters in Latin America and tested for resistance to isoniazid, streptomycin, rifampicin, ethambutol, and thioacetazone. Initial drug resistance, although unevenly distributed, was detected in all the clusters tested and characterized one out of every six tuberculosis cases.
View Article and Find Full Text PDFJ Virol
October 1992
National Laboratory for Immunology, Laboratory Center for Disease Control, Ottawa, Ontario, Canada.
Monoclonal antibodies (MAbs) directed against the prototype enterovirus 70 (EV-70) strain J670/71 were generated and characterized in order to produce anti-idiotypic MAbs (MAb2s) for use as surrogate immunogens. Western immunoblot and radioimmunoprecipitation assays suggested that all the MAbs recognize conformational epitopes on the virion surface. An EV-70-neutralizing antibody, MAb/ev-12 (MAb1), was selected for the production of MAb2s.
View Article and Find Full Text PDFInt J Lepr Other Mycobact Dis
September 1992
Laboratory Center for Disease Control, Department of Health and Welfare, Ottawa, Canada.
Two glycolipids--one synthetic and non-natural (BDA.TDA), the other natural and Mycobacterium tuberculosis species-specific (SL-IV)--were tested to determine their serological activity in sera obtained from leprosy patients, and to determine their discriminating ability in the detection of disease. The ELISA results obtained in the IgG antibody class show that both were useful substances capable of detecting multibacillary and paucibacillary disease in about 2 out of 3 leprosy patients.
View Article and Find Full Text PDFJ Natl Cancer Inst
March 1992
Bureau of Chronic Disease Epidemiology, Laboratory Center for Disease Control, Health and Welfare, Ottawa, Ont., Canada.
Background: The incidence of brain cancer has increased dramatically over the last decades in most developed countries. Whether these trends can be attributed to improved diagnosis is not clear.
Purpose: To determine the effect of new imaging technology on increased rates of brain cancer, we assessed the level of detection for neurological disorders when computed tomography (CT) and magnetic resonance imaging (MRI) results were not available.
Viral Immunol
July 1992
National Laboratory for Immunology, Laboratory Center for Disease Control, Ottawa, Ontario, Canada.
Two new monoclonal antibodies, CIE-1 and CIE-2, were developed for the rapid detection of human cytomegalovirus (HCMV) infection. They were found to be reactive with immediate early protein of HCMV in the nuclei of infected fibroblasts, as early as 3 hours post-infection. By radioimmunoprecipitation, CIE-1 was found to react with a protein with an apparent molecular weight of 70,000, whereas CIE-2 precipitated 2 proteins of 70,000 and 72,000 daltons, respectively.
View Article and Find Full Text PDFViral Immunol
August 1990
National Laboratory for Immunology, Laboratory Center for Disease Control, Ottawa, Ontario, Canada.
A library of murine monoclonal antibodies against the prototype Enterovirus-70 (EV-70) strain, J670/71, was made for the purpose of studying the immunologically reactive determinants of the virus. Each of the monoclonal antibodies reacted with several other strains of Enterovirus-70 when tested by immunofluorescence. However, none of these monoclonal antibodies reacted with any other picornavirus tested.
View Article and Find Full Text PDFComput Appl Biosci
November 1987
Laboratory Center for Disease Control, Molecular Virology Laboratory, Ottawa, Ontario, Canada.